BeiGene, a global biotech firm that develops cancer medicines, has opened a 400,000-square-foot life sciences facility in ...
Hosted on MSN10d
ImmunityBio Stock Soars On BeiGene Tie-Up, Supply Deal: Retail Gets Dose Of OptimismImmunityBio shares surged as much as 14% on Wednesday, reaching their highest level in nearly seven weeks while lifting ...
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on BeiGene (ONC – Research Report) and Embecta ...
GlobalData on MSN9d
ImmunityBio and BeiGene partner on Phase III trial of NSCLC treatment comboImmunityBio has entered a supply agreement and partnership with BeiGene for conducting a confirmatory Phase III ...
The Phase III trial builds on findings from prior findings that indicated Anktiva can restore T-cell function and improve ...
TipRanks on MSN6d
BeiGene Announces Share Options and RSUs GrantBeiGene Ltd ( ($HK:6160) ) has issued an announcement. BeiGene Ltd., a biopharmaceutical company, announced the grant of share options and ...
In a report released yesterday, Kelly Shi from Jefferies reiterated a Buy rating on BeiGene (ONC – Research Report), with a price target of ...
California-based ImmunityBio has entered into a collaboration and supply agreement with Sino-American biotech BeiGene (to be ...
ImmunityBio shares were up 14% to $3.52 after the company entered into a collaboration and supply agreement with BeiGene. The two companies will conduct a confirmatory randomized Phase 3 clinical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback